These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1486921)

  • 21. The role of pretreatment squamous cell carcinoma antigen level in locally advanced squamous cell carcinoma of the uterine cervix treated by radiotherapy.
    Ogino I; Nakayama H; Okamoto N; Kitamura T; Inoue T
    Int J Gynecol Cancer; 2006; 16(3):1094-100. PubMed ID: 16803491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
    Li D; Xu XX; Yan DD; Yuan SH; Lou HM
    Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
    [No Abstract]   [Full Text] [Related]  

  • 23. Expression of mRNA of SCC antigen in squamous cells.
    Takeshima N; Suminami Y; Takeda O; Abe H; Okuno N; Kato H
    Tumour Biol; 1992; 13(5-6):338-42. PubMed ID: 1290029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervix.
    Crombach G; Scharl A; Vierbuchen M; Würz H; Bolte A
    Cancer; 1989 Apr; 63(7):1337-42. PubMed ID: 2920361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum squamous cell carcinoma antigen in gynecologic malignancies with special reference to cervical cancer.
    Hsieh CY; Chang DY; Huang SC; Yen ML; Juang GT; Ouyang PC
    Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):797-800. PubMed ID: 2592943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Squamous cell carcinoma antigen for monitoring cervical cancer.
    Schmidt-Rhode P; Schulz KD; Sturm G; Häfner H; Prinz H; Künzig HJ
    Int J Biol Markers; 1988; 3(2):87-94. PubMed ID: 3243981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance of determination of squamous cell carcinoma antigen in the follow up of patients with cancer of the uterine cervix].
    Göcze P; Vahrson H
    Orv Hetil; 1992 Dec; 133(50):3191-4. PubMed ID: 1461640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between squamous cell carcinoma-associated antigen and CA-125 in patients with carcinoma of the cervix.
    Lehtovirta P; Viinikka L; Ylikorkala O
    Gynecol Oncol; 1990 May; 37(2):276-8. PubMed ID: 2344974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
    Geyer H; Schwörer D; Pfleiderer A
    Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):266-71. PubMed ID: 2721888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experiences with the squamous cell carcinoma antigen, a new tumor marker for cancer of the uterine cervix].
    Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Hepp H
    Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):625-9. PubMed ID: 2777050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
    Duk JM; Groenier KH; de Bruijn HW; Hollema H; ten Hoor KA; van der Zee AG; Aalders JG
    J Clin Oncol; 1996 Jan; 14(1):111-8. PubMed ID: 8558185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors regulating SCC antigen expression in squamous cell carcinoma of the uterine cervix.
    Maruo T; Yoshida S; Samoto T; Tateiwa Y; Peng X; Takeuchi S; Motoyama S
    Tumour Biol; 1998; 19(6):494-504. PubMed ID: 9817979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of pretreatment squamous cell carcinoma antigen in predicting nodal metastasis in early stage cervical cancer.
    Lin H; ChangChien CC; Huang EY; Tseng CW; Eng HL; Huang CC
    Acta Obstet Gynecol Scand; 2000 Feb; 79(2):140-4. PubMed ID: 10696963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum squamous cell carcinoma antigen levels in women with neoplasms of the lower genital tract and in healthy controls.
    Neunteufel W; Tatra G; Bieglmayer C
    Arch Gynecol Obstet; 1989; 246(4):243-50. PubMed ID: 2619339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SCC antigen measured in malignant and nonmalignant diseases.
    Molina R; Filella X; Torres MD; Ballesta AM; Mengual P; Cases A; Balaque A
    Clin Chem; 1990 Feb; 36(2):251-4. PubMed ID: 2302769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Power Doppler angiographic appearance and blood flow velocity waveforms in invasive cervical carcinoma.
    Wu YC; Yuan CC; Hung JH; Chao KC; Yen MS; Ng HT
    Gynecol Oncol; 2000 Nov; 79(2):181-6. PubMed ID: 11063641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Squamous cell carcinoma antigen in patients with cancer of the uterine cervix.
    Fuith LC; Daxenbichler G
    Gynecol Obstet Invest; 1988; 26(1):77-82. PubMed ID: 3169633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can serial evaluation of serum SCC-Ag-level predict tumor recurrence and patient survival in squamous-cell carcinoma of uterine cervix treated with definitive chemoradiotherapy? A multi-institutional analysis.
    Choi KH; Yu M; Jeong S; Lee JH
    Int J Clin Oncol; 2020 Jul; 25(7):1405-1411. PubMed ID: 32221801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transformation of histological tumor type of the cervix expressed in different tumor markers in the serum.
    Aalders JG; de Bruijn HW; Oosterhuis JW; Duk JM
    Gynecol Oncol; 1990 Jan; 36(1):110-2. PubMed ID: 2295441
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.